Clinical trials
Expanded access Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Available | 3 |
| No longer available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Celgene | 1 |
| GlaxoSmithKline | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 5 |
| Endometrial Neoplasms | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
| Multiple Myeloma | 1 |
| Polycythemia Vera | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Sarcoma | 1 |
Trials
Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.